Nutraplus India Ltd.
BSE: 524764 | Sector: Health care |
NSE: N.A. | ISIN Code: INE230G01020 |
BSE 00:00 | 13 Dec | Nutraplus India Ltd |
NSE 05:30 | 01 Jan | Nutraplus India Ltd |
OPEN | 1.90 |
PREVIOUS CLOSE | 2.10 |
VOLUME | 43184 |
52-Week high | 2.75 |
52-Week low | 1.82 |
P/E | |
Mkt Cap.(Rs cr) | 7 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Nutraplus India Ltd. (NUTRAPLUSINDIA) - Company Information
Nutraplus Products (India) Limited was originally incorporated as a private limited company on 6 Feb.'90. It was subsequently converted into a public limited company with effect from 13 Jun.'92. The company implemented a project for the manufacture of veterinary bulk drugs namely dimentridazole (DMZ) and dinitolmide (DOT) at Tarapur Maharashtra. Initially the company set up manufacturing facilitie...> More
COMPANY INFORMATION | |||||||
Chairman & Managing Director : | Mukesh D Naik | ||||||
Independent Director : | Vinod Laxman Parab | ||||||
Non-Exec. & Independent Dir. : | Nitin Desai | ||||||
Company Secretary : | Nancy Napoleon | ||||||
Non-Exec. & Independent Dir. : | Leena Chitalia | ||||||
AUDITOR : | Raman S Shah & Associates | ||||||
IND NAME : | Pharmaceuticals - Indian - Bulk Drugs | ||||||
HOUSE NAME : | Indian Private | ||||||
Registered office | |||||||
Plot No N-92, MIDC-Tarapur Boisar,Thane,Maharashtra-401506 | |||||||
Ph : | |||||||
WEBSITE : http://www.nutraplusindia.com | |||||||
E-mail : nutraplus@gmail.com |
Quick Links for Nutraplus India:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices